NCT06509581View on ClinicalTrials.gov

Vitamin E Supplementation for Children With Transfusion Dependent Beta Thalassemia on Different Iron Chelation Regimen

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 5, 2021

Primary Completion Date

September 11, 2022

Study Completion Date

October 11, 2022

Conditions
Beta-Thalassemia
Interventions
DIETARY_SUPPLEMENT

vitamin E

Vitamin E will be taken for 12 months for beta thalassemia patiens on regular packed red blood cell transfusion and chelators(desferoxamine,deferiprone and deferasirox )

OTHER

PLACEBO

placebo will be taken for 12 months for beta thalassemia patiens on regular packed red blood cell transfusion and chelators(desferoxamine,deferiprone and deferasirox )

Trial Locations (1)

11517

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER